~~<i id='7D7C47FB33'><strike id='7D7C47FB33'><tt id='7D7C47FB33'><pre id='7D7C47FB33'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

hotspot

author：hotspot 2025-09-29 16:21:01 - browse：5

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how tech is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

FDA approves device to save limbs of vascular disease patients

An innocuous slip while cutting her toenails created a wound on Cynthia Elford’s right foot that wouldn’t heal.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： 4th of July breaks record for highest global temperature ever measured

leisure time

knowledge

leisure time

hotspot

leisure time

explore

5:11InthisFeb.1,2023,filephoto,apieceofequipmentcalledadistributorusedtoholdtraysoflimestoneforcaptu

WSS

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Inside the fall of star MIT scientist David Sabatini

NIH documents show early flaws of $1.6 billion long Covid program

Why is France rioting? What to know about the fatal police shooting of Nahel M

New case study details death in closely watched Alzhiemer's trial

Ionis drug prevents swelling attacks due to hereditary angioedema

explore

hotspot

leisure time

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Innovation in antibiotics is ailing. 'Brain drain' may kill it

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Cord blood banking comes at a high cost to babies

DIEP, the 'gold standard' of breast reconstruction, is under threat

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Duchenne breakthrough therapy leaves behind pioneering families

At ASCO, AstraZeneca reports strong data for breast cancer drug

Medical records are filled with copy

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

knowledge

Australia's humpback populations rebound raising hopes of marine scientists

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

A new study asks: Are we harming blood donors by taking blood?

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

These geoengineering technologies could help combat the climate crisis, scientists say

Ultragenyx gene therapy for rare liver ailment succeeds in late

leisure time

hotspot

leisure time

explore